Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes

We examined associations of advanced glycation end products (AGEs) with renal function loss (RFL) and its structural determinants in American Indians with type 2 diabetes. Data were from a 6-year clinical trial that assessed renoprotective efficacy of losartan. Participants remained under observatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Saulnier, Pierre-Jean, Wheelock, Kevin M., Howell, Scott, Weil, E. Jennifer, Tanamas, Stephanie K., Knowler, William C., Lemley, Kevin V., Mauer, Michael, Yee, Berne, Nelson, Robert G., Beisswenger, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2016
Materias:
Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127241/
https://www.ncbi.nlm.nih.gov/pubmed/27609106
http://dx.doi.org/10.2337/db16-0310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127241/
https://www.ncbi.nlm.nih.gov/pubmed/27609106
http://dx.doi.org/10.2337/db16-0310

Ejemplares similares